A dissolvable oral dispersible film of dolutegravir could transform treatment ANALYSIS | MELODY CHIRONDA | In the fight ...

Kenya is among six African countries at risk of running out of HIV drugs following the recent decision by the US government ...

Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss statements.

Previous research has suggested an increased risk for neuropsychiatric symptoms in people living with HIV who are being ...

Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...

The cancellation of USAID contracts has threatened critical global health research. Plus, new guidance to prevent HIV in ...

Patients are grappling with a shortage of HIV drugs even as an emergency consignment worth $34 million (Sh4.4bn) has been ...

The PETITE study is evaluating two formulations of dolutegravir in newborn babies under 4 weeks of age – an oral film. In the ...

Dolutegravir is one of the most effective and safest HIV medicines and is used by millions of adults and adolescents living with HIV in over 100 countries. But there’s no specific drug formulation for ...

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

The global HIV drugs industry was valued at USD 28.6 billion in 2023 and is projected to grow at a CAGR of 4.7% from 2024 to ...

Newborns remain one of the most overlooked populations in the fight against HIV, with an estimated 120,000 new infections ...